{"id":"https://openalex.org/W7124465733","doi":"https://doi.org/10.1080/00914037.2025.2612538","title":"Lipid based nanoformulations for targeted delivery of neuroactives in migraine therapy","display_name":"Lipid based nanoformulations for targeted delivery of neuroactives in migraine therapy","publication_year":2026,"publication_date":"2026-01-16","ids":{"openalex":"https://openalex.org/W7124465733","doi":"https://doi.org/10.1080/00914037.2025.2612538"},"language":"en","primary_location":{"id":"doi:10.1080/00914037.2025.2612538","doi":"https://doi.org/10.1080/00914037.2025.2612538","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00914037.2025.2612538","pdf_url":null,"source":{"id":"https://openalex.org/S176437474","display_name":"International Journal of Polymeric Materials","issn_l":"0091-4037","issn":["0091-4037","1026-7751","1563-535X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Polymeric Materials and Polymeric Biomaterials","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5099116631","display_name":"Priyanka Gawarkar\u2010Patil","orcid":"https://orcid.org/0009-0003-0832-3672","observed_orcids":["https://orcid.org/0009-0003-0832-3672"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Priyanka Gawarkar-Patil","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University)"],"raw_orcid":"https://orcid.org/0009-0003-0832-3672","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University)","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044280510","display_name":"Vividha S. Dhapte-Pawar","orcid":"https://orcid.org/0000-0002-2215-2676","observed_orcids":["https://orcid.org/0000-0002-2215-2676"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Vividha Dhapte-Pawar","raw_affiliation_strings":["Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University)"],"raw_orcid":"https://orcid.org/0000-0002-2215-2676","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University)","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023283854","display_name":"Bijoy Kumar Panda","orcid":"https://orcid.org/0000-0001-8807-196X","observed_orcids":["https://orcid.org/0000-0001-8807-196X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bijoy Kumar Panda","raw_affiliation_strings":["Department of Pharmacy Practice, Krishna Institute of Pharmacy, Krishna Vishwa Vidyapeeth (Deemed to be University)"],"raw_orcid":"https://orcid.org/0000-0001-8807-196X","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Krishna Institute of Pharmacy, Krishna Vishwa Vidyapeeth (Deemed to be University)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095859343","display_name":"Bhavna Mahajan","orcid":"https://orcid.org/0009-0000-1770-1100","observed_orcids":["https://orcid.org/0009-0000-1770-1100"]},"institutions":[{"id":"https://openalex.org/I4387152961","display_name":"Vishwakarma University","ror":"https://ror.org/016zwj547","country_code":"IN","type":"education","lineage":["https://openalex.org/I4387152961"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Bhavna Mahajan","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmacy, Vishwakarma University"],"raw_orcid":"https://orcid.org/0009-0000-1770-1100","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, Vishwakarma University","institution_ids":["https://openalex.org/I4387152961"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080365390","display_name":"Pratibha R. Adnaik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141641110","display_name":"Shivaji University","ror":"https://ror.org/01bsn4x02","country_code":"IN","type":"education","lineage":["https://openalex.org/I141641110"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pratibha Adnaik","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Anandi Pharmacy College, Kalambe, Shivaji University"],"raw_orcid":"https://orcid.org/0009-0002-0122-8624","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Anandi Pharmacy College, Kalambe, Shivaji University","institution_ids":["https://openalex.org/I141641110"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5044280510"],"corresponding_institution_ids":["https://openalex.org/I887998513"],"apc_list":null,"apc_paid":null,"fwci":1.308,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.7059141,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"75","issue":"8","first_page":"904","last_page":"920"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.2485000044107437,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.11379999667406082,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.9559999704360962},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8019999861717224},{"id":"https://openalex.org/keywords/drug-delivery-systems","display_name":"drug delivery systems","score":0.6850000023841858},{"id":"https://openalex.org/keywords/cgrp-antagonists","display_name":"CGRP antagonists","score":0.7829999923706055},{"id":"https://openalex.org/keywords/gepants","display_name":"gepants","score":0.7839999794960022},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9110000133514404},{"id":"https://openalex.org/keywords/5-ht1f-receptor-agonist","display_name":"5-HT1F receptor agonist","score":0.9620000123977661},{"id":"https://openalex.org/keywords/ditans","display_name":"ditans","score":0.9850000143051147},{"id":"https://openalex.org/keywords/controlled-release","display_name":"controlled release","score":0.6930000185966492},{"id":"https://openalex.org/keywords/encapsulation","display_name":"encapsulation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/neuroactive-drugs","display_name":"neuroactive drugs","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8255000114440918},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7685999870300293},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45719999074935913},{"id":"https://openalex.org/C2911171718","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine Disorders","level":3,"score":0.37700000405311584},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.3617999851703644},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33739998936653137},{"id":"https://openalex.org/C2780564907","wikidata":"https://www.wikidata.org/wiki/Q6844299","display_name":"Migraine treatment","level":3,"score":0.3066999912261963},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2935999929904938},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.27619999647140503},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.2718000113964081},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2632000148296356},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.25999999046325684},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.25850000977516174}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1080/00914037.2025.2612538","doi":"https://doi.org/10.1080/00914037.2025.2612538","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00914037.2025.2612538","pdf_url":null,"source":{"id":"https://openalex.org/S176437474","display_name":"International Journal of Polymeric Materials","issn_l":"0091-4037","issn":["0091-4037","1026-7751","1563-535X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Polymeric Materials and Polymeric Biomaterials","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":114,"referenced_works":["https://openalex.org/W1132060477","https://openalex.org/W1904976945","https://openalex.org/W1959587626","https://openalex.org/W1983682440","https://openalex.org/W2081960810","https://openalex.org/W2091830348","https://openalex.org/W2133001175","https://openalex.org/W2204733280","https://openalex.org/W2205085873","https://openalex.org/W2337531481","https://openalex.org/W2344698737","https://openalex.org/W2399750252","https://openalex.org/W2556659313","https://openalex.org/W2563167190","https://openalex.org/W2563963730","https://openalex.org/W2616802361","https://openalex.org/W2624317658","https://openalex.org/W2735486104","https://openalex.org/W2764194592","https://openalex.org/W2768357559","https://openalex.org/W2770965214","https://openalex.org/W2771927282","https://openalex.org/W2779389688","https://openalex.org/W2784163112","https://openalex.org/W2790852710","https://openalex.org/W2792579458","https://openalex.org/W2792811290","https://openalex.org/W2793972985","https://openalex.org/W2800424506","https://openalex.org/W2803715733","https://openalex.org/W2805181790","https://openalex.org/W2805739889","https://openalex.org/W2805937849","https://openalex.org/W2843205677","https://openalex.org/W2916511243","https://openalex.org/W2970903952","https://openalex.org/W3002080991","https://openalex.org/W3008327462","https://openalex.org/W3009643545","https://openalex.org/W3013502865","https://openalex.org/W3017095400","https://openalex.org/W3020893400","https://openalex.org/W3027556885","https://openalex.org/W3033018060","https://openalex.org/W3037379202","https://openalex.org/W3038017652","https://openalex.org/W3082219892","https://openalex.org/W3092563204","https://openalex.org/W3092849554","https://openalex.org/W3107691911","https://openalex.org/W3120388370","https://openalex.org/W3129570026","https://openalex.org/W3131502707","https://openalex.org/W3134254717","https://openalex.org/W3150487324","https://openalex.org/W3156272201","https://openalex.org/W3158157872","https://openalex.org/W3160771586","https://openalex.org/W3165871675","https://openalex.org/W3173551259","https://openalex.org/W3177167583","https://openalex.org/W3199136853","https://openalex.org/W3210931446","https://openalex.org/W3212380527","https://openalex.org/W4200376541","https://openalex.org/W4212953466","https://openalex.org/W4213117238","https://openalex.org/W4214623848","https://openalex.org/W4220795266","https://openalex.org/W4221125869","https://openalex.org/W4281673424","https://openalex.org/W4282934967","https://openalex.org/W4282944494","https://openalex.org/W4283069497","https://openalex.org/W4283742022","https://openalex.org/W4284691484","https://openalex.org/W4285014255","https://openalex.org/W4285206591","https://openalex.org/W4291147620","https://openalex.org/W4293004990","https://openalex.org/W4308424543","https://openalex.org/W4308834147","https://openalex.org/W4310037088","https://openalex.org/W4312018577","https://openalex.org/W4313361463","https://openalex.org/W4318000278","https://openalex.org/W4318480239","https://openalex.org/W4318824660","https://openalex.org/W4320006581","https://openalex.org/W4323921031","https://openalex.org/W4323929201","https://openalex.org/W4324021052","https://openalex.org/W4368340939","https://openalex.org/W4383313642","https://openalex.org/W4385431697","https://openalex.org/W4385460078","https://openalex.org/W4386269737","https://openalex.org/W4386369694","https://openalex.org/W4388636442","https://openalex.org/W4389099126","https://openalex.org/W4389254186","https://openalex.org/W4392006792","https://openalex.org/W4392111751","https://openalex.org/W4392878061","https://openalex.org/W4393392488","https://openalex.org/W4396660040","https://openalex.org/W4399379175","https://openalex.org/W4400133989","https://openalex.org/W4400409650","https://openalex.org/W4400865597","https://openalex.org/W4402513912","https://openalex.org/W4403134231","https://openalex.org/W4412750851","https://openalex.org/W4413044104"],"related_works":["https://openalex.org/W4406964018","https://openalex.org/W4403134231","https://openalex.org/W7203440574","https://openalex.org/W4414027144","https://openalex.org/W7162003013","https://openalex.org/W4400835307","https://openalex.org/W4403142854","https://openalex.org/W4407615130","https://openalex.org/W7117684118","https://openalex.org/W4288418948"],"abstract_inverted_index":{"Migraine":[0],"is":[1,7,85],"a":[2,50,156,179],"prolonged":[3],"neurological":[4],"condition":[5],"and":[6,27,101,125,133],"ranked":[8],"as":[9,96],"the":[10,55,61,71,160,167],"second":[11],"leading":[12],"cause":[13],"of":[14,25,29,39,68,162],"years":[15],"lived":[16],"with":[17,155,178,189],"disability":[18],"(YLDs)":[19],"worldwide.":[20],"Migraines":[21],"impact":[22],"over":[23],"18%":[24],"women":[26],"6%":[28],"men":[30],"annually,":[31],"significantly":[32],"impairing":[33],"daily":[34],"activities":[35],"that":[36,52,80],"diminish":[37],"quality":[38],"life":[40],"(QoL).":[41],"Despite":[42],"its":[43],"prevalence,":[44],"migraine":[45,195],"remains":[46],"largely":[47],"untreated,":[48],"mainly":[49],"problem":[51],"arises":[53],"from":[54],"blood-brain":[56],"barrier":[57],"(BBB),":[58],"which":[59,98],"confines":[60],"brain\u2019s":[62],"ability":[63],"to":[64],"receive":[65],"effective":[66],"concentrations":[67],"actives.":[69],"Thus,":[70],"necessity":[72],"for":[73,117,153,186],"an":[74,89,118],"innovative":[75],"drug":[76,112],"delivery":[77,188],"system":[78],"(DDS)":[79],"can":[81,114],"surpass":[82],"these":[83],"obstacles":[84],"essential.":[86],"Nanotechnology":[87],"provides":[88],"encouraging":[90],"approach":[91],"by":[92,107],"employing":[93,108],"strategies":[94],"such":[95],"encapsulation,":[97],"enhance":[99],"stability":[100],"facilitate":[102],"targeted":[103],"brain":[104,187],"delivery.":[105],"Furthermore,":[106],"controlled":[109],"release":[110],"mechanisms,":[111],"levels":[113],"be":[115],"maintained":[116],"extended":[119],"period,":[120],"thereby":[121],"lowering":[122],"dosing":[123],"frequency":[124],"systemic":[126],"side":[127],"effects.":[128],"This":[129,169],"review":[130,170],"underlines":[131],"pathophysiology":[132],"current":[134,174],"treatment":[135],"strategies,":[136],"specifically":[137],"calcitonin":[138],"gene-related":[139],"peptide":[140],"(CGRP)":[141],"antagonists":[142],"(gepants),":[143],"monoclonal":[144],"antibodies":[145],"(mAbs),":[146],"also":[147],"5-hydroxytryptamine":[148],"(5-HT1F)":[149],"receptor":[150],"agonists":[151],"(ditans)":[152],"migraine,":[154],"specific":[157],"focus":[158],"on":[159,192],"role":[161],"lipid":[163,183],"nanoparticles":[164],"in":[165,194],"bypassing":[166],"BBB.":[168],"combines":[171],"mechanistic":[172],"insights,":[173],"clinical":[175],"trial":[176],"data,":[177],"comparative":[180],"overview":[181],"about":[182],"nanoformulations":[184],"investigated":[185],"special":[190],"emphasis":[191],"neuroactives":[193],"therapy.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-01-17T00:00:00"}